Journal
CLINICAL NUTRITION
Volume 31, Issue 3, Pages 396-404Publisher
CHURCHILL LIVINGSTONE
DOI: 10.1016/j.clnu.2011.10.015
Keywords
Peri-operative care; Neoplasm metastasis; Natural killer cells; Omega-3 fatty acids; Fish oil
Categories
Funding
- NIH/NCI [CA125456]
Ask authors/readers for more resources
Background & aims: Omega-3 fatty acids (omega-3FA) attenuate postoperative immunosuppression vis-a-vis infection. Since immune-surveillance targets metastasizing cancer cells, we assessed the effect of omega-3FA consumption on 1) early post-operative Natural Killer cell (NK) cytotoxicity and metastases and 2) long-term recurrence-free survival, in two rodent models of surgery-promoted metastases. Methods: C57BL/6J mice were fed standard, omega-3FA-enriched, or omega-6FA-enriched chow, beginning one week before subcutaneous footpad implantation of syngeneic melanoma cells. When tumors reached the volume of 110 mu l, the tumor-bearing footpad was amputated, and long-term recurrence-free survival was assessed. Also, F344 rats were fed omega-3FA or omega-6FA for a month before undergoing or not undergoing laparotomy, and were intravenously inoculated with radio-labeled syngeneic adenocarcinoma cells. Marginating-pulmonary (MP)-leukocytes were harvested, and lung tumor retention (LTR) of metastases was assessed. Results: omega-3FA consumption did not affect the growth of footpad tumors, but significantly enhanced post-amputation recurrence-free survival in mice. Surgery had a deleterious effect on NK cell activity and LTR whereas omega-3FA had large beneficial effects in non-operated rats and an even greater impact in operated rats. Conclusions: omega-3FA feeding attenuates or even overcomes postoperative NK cell suppression, increases resistance to experimental and spontaneous metastasis, and enhances recurrence-free survival following excision of metastasizing primary tumors. These findings warrant clinical studies of omega-3FA-based nutrition in patients undergoing resection of a primary tumor. (C) 2011 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available